FMP
Adaptimmune Therapeutics plc
ADAP
NASDAQ
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposarcoma indications (MRCLS); in phase II clinical trials with SPEARHEAD-2 for patients with head and neck cancer; and in phase I clinical trials for urothelial, melanoma, head and neck, ovarian, non-small cell lung, esophageal and gastric, synovial sarcoma, and MRCLS cancers. The company is also developing ADP-A2AFP, which is in phase I clinical trials for hepatocellular carcinoma; and ADP-A2M4CD8, which is in phase I clinical trial for SPEAR T-cells focusing on treating patients with lung, gastroesophageal, head and neck, ovarian, and bladder cancers. It has a collaboration and license agreement with GSK; third party collaborations with Noile-Immune Biotech Inc., Alpine Immune Sciences, Inc., and National Center for Cancer Immune Therapy in Denmark; strategic alliance agreement with the MD Anderson Cancer Center; and co-development and co-commercialization agreement with Universal Cells, Inc. Adaptimmune Therapeutics plc also has a strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic T-cell therapies utilizing aß T-cell receptors. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
0.663 USD
0.0134 (2.02%)
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
89.54M
368.22M
369.58M
204.6M
146.94M
113.83M
214.96M
405.93M
766.56M
1.45B
7.98k
9.3k
6.01k
753.67
243.76
100
100
100
100
19.28M
139k
752k
7.43M
46.92M
50.31M
95M
179.39M
338.76M
639.72M
1.72k
3.51
12.23
27.39
77.83
44.19
44.19
44.19
44.19
1.46M
2.09M
746k
1.28M
-
38.6M
72.89M
137.65M
259.94M
490.86M
130.04
52.7
12.13
4.71
-
33.91
33.91
33.91
33.91
6.36M
6.39M
8.11M
4.75M
8.13M
75.36M
142.3M
268.72M
507.45M
958.27M
566.58
161.42
131.94
17.51
13.48
66.2
66.2
66.2
66.2
-3.07M
-2.91M
-8.78M
-29.74M
-4.88M
-86.86M
-164.02M
-309.74M
-584.91M
-1.1B
-273.98
-73.42
-142.8
-109.55
-8.1
-76.3
-76.3
-76.3
-76.3